Angiogenesis inhibition and lung-cancer therapy

Lancet Oncol. 2014 Feb;15(2):124-5. doi: 10.1016/S1470-2045(14)70010-5.

Authors

Amir Onn¹, Jair Bar², Roy S Herbst³

Affiliations

¹ Sheba Medical Center, Institute of Pulmonology, Tel Hashomer, Ramat Gan, Israel.
² Institute of Oncology, Tel Hashomer, Ramat Gan, Israel.
³ Yale Cancer Center, Section of Medical Oncology, New Haven, CT 06520, USA. Electronic address: roy.herbst@yale.edu.

PMID: 24480554
DOI: 10.1016/S1470-2045(14)70010-5

No abstract available

Publication types

Comment

MeSH terms

Adenocarcinoma / drug therapy*
Adenocarcinoma of Lung
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lung Neoplasms / drug therapy*
Male